Arena Pharmaceuticals, Inc. Message Board
-
Belviq Will Dwarf Lipitor
Just between friends, family and co workers I'm counting 9 users
You?-
Lipior works well for its intended use
-
yuppers
-
Well phrased
-
tell all to go to gym, but 97% do not follow advice
-
$12B annual revenues for Lipitor the last 6-7 years of its patent life. Belviq has several applications which can spur growth here - not just one. So . . . who knows what the up side is. I have stated before that I think Belviq can approach or beat that number with worldwide distribution. Of course not all of that will fall to ARNA as we know. Still the dollars should be huge. JMO
- 1 Reply to jdolby32
-
Agree .. Belviq can go farther
-
Every other walmart shopper may be a client.
- 2 Replies to outsiderinfo
-
That's too conservative, I think 4 out of 5 Walmart shopper may be a client.
Sentiment: Strong Buy
-
BLOCKBUSTER
-
We held Warner Lambert through the run up of Lipitor. We've now held ARNA since 2009. It may not hit the numbers of Lipitor, but even getting close will be fine with us. Thanks S. Vig!!!
Cheers- 3 Replies to jpjaz2010
-
Three weeks to launch date...
JUNE 7TH....
Just reminding the market, since it only thinks about 5 minutes ahead in time.
Hey Mr. Market... time to WAKE UP.... -
still doctors will have to monitor side effects like valveopathy I think.
-
right on!
Sentiment: Buy
-